Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2026-07-06 19:59:55 ET · period of report 2026-06-18 · accession 0001140361-26-027676 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-06 19:59 | 2026-06-18 | RCKT | BOESS CARSTEN | Dir | A - Grant | $0.00 | +22.9K | 52.9K | +76% | $0 |
| D | 2026-07-06 19:59 | 2026-06-18 | RCKT | BOESS CARSTEN | Dir | A - Grant | $0.00 | +64.9K | 64.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-18 | A | A | 22,862 | $0.00 | 52,862 | D | — | — | (F1) Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027. (F1) Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2027. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-18 | A | A | 64,860 | $0.00 | 64,860 | D | $3.35 · — to 2036-06-18 | 64,860 Common Stock | (F2) This option represents a right to purchase a total of 64,860 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 18, 2027. |